Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Nanosonics Limited ( (AU:NAN) ) has shared an announcement.
UBS Group AG and its related bodies corporate have ceased to be substantial shareholders of Nanosonics Limited as of November 3, 2025. This change in shareholding could impact the company’s shareholder structure and influence its market perception, potentially affecting investor confidence and the company’s strategic decisions.
The most recent analyst rating on (AU:NAN) stock is a Buy with a A$5.00 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited operates in the medical technology industry, specializing in infection prevention solutions. The company is known for its innovative products, particularly in the area of ultrasound probe disinfection, and focuses on enhancing patient safety and reducing healthcare-associated infections.
Average Trading Volume: 737,564
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$1.37B
For detailed information about NAN stock, go to TipRanks’ Stock Analysis page.